Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Synthetic double-stranded siRNA oligonucleotide directed against transthyretin mRNA

EU orphan designation number: EU/3/11/857   
Active ingredient: Synthetic double-stranded siRNA oligonucleotide directed against transthyretin mRNA
Indication: Treatment of familial amyloid polyneuropathy
Sponsor: Alnylam UK Limited
5 New Street Square, London EC4A 3TW, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
19/04/2011 Centralised Orphan - Designation EMA/OD/142/10 (2011)2844 of 15/04/2011
13/11/2014 Centralised Orphan - Transfer of orphan designation EMA/OD/142/10/T/01 (2014)8536 of 11/11/2014